N106-1267 Screening compound: 4-[(1R,3aS,10aS,10bS)-2-(3-methoxybenzoyl)decahydro-1H,4H-pyrido[3,2,1-ij][1,6]naphthyridin-1-yl]-N~1~-benzylbutanamide

N106-1267 Screening compound: 4-[(1R,3aS,10aS,10bS)-2-(3-methoxybenzoyl)decahydro-1H,4H-pyrido[3,2,1-ij][1,6]naphthyridin-1-yl]-N~1~-benzylbutanamide
N106-1267 Screening compound: 4-[(1R,3aS,10aS,10bS)-2-(3-methoxybenzoyl)decahydro-1H,4H-pyrido[3,2,1-ij][1,6]naphthyridin-1-yl]-N~1~-benzylbutanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound N106-1267
4-[(1R,3aS,10aS,10bS)-2-(3-methoxybenzoyl)decahydro-1H,4H-pyrido[3,2,1-ij][1,6]naphthyridin-1-yl]-N~1~-benzylbutanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

N106-1267

Molecular Formula

C30H39N3O3 (C30 H39 N3 O3)

Compound Name

4-[(1R,3aS,10aS,10bS)-2-(3-methoxybenzoyl)decahydro-1H,4H-pyrido[3,2,1-ij][1,6]naphthyridin-1-yl]-N~1~-benzylbutanamide

IUPAC name

N-benzyl-4-[(5R6R9S13S)-7-(3-methoxybenzoyl)-17-diazatricyclo[7.3.1.0^{513}]tridecan-6-yl]butanamide

SMILES

COc1cccc(C(N(C[C@@H]2CCC3)[C@H](CCCC(NCc4ccccc4)=O)[C@@H]4[C@H]2N3CCC4)=O)c1

InChI

InChI=1S/C30H39N3O3/c1-36-25-13-5-11-23(19-25)30(35)33-21-24-12-7-17-32-18-8-14-26(29(24)32)27(33)15-6-16-28(34)31-20-22-9-3-2-4-10-22/h2-5,9-11,13,19,24,26-27,29H,6-8,12,14-18,20-21H2,1H3,(H,31,34)/t24-,26-,27-,29-/m1/s1

InChI Key

XTZKCOQDYWUTBJ-UNXBZVTQSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

489.66

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.133

Distribution Coefficient, logD

0.672

Water Solubility, LogSw

-3.41

Polar Surface Area

50.936

Acid Dissociation Constant (pKa)

13.01

Base Dissociation Constant (pKb)

9.86

Number of Chiral Centers

4.00

Percent sp3 carbon bonding

53.33

N106-1267 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with N106-1267 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound N106-1267?
Check Price and Availability of N106-1267, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of N106-1267 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for N106-1267
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for N106-1267
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of N106-1267 available by request